Tibial Tuberosity Advancement (TTA)
Surgical repair of cranial cruciate deficiency is one of the most common small animal orthopedic procedures, due not only to the high incidence of the problem, but also to the clinical success of recent surgical techniques.
KYON launched TTA for cranial cruciate deficiency in dogs in early 2004, following three years of clinical testing. Slobodan Tepic, Dr. Sci., Dipl. Ing., and Prof. Pierre M. Montavon, Head of Small Animal Surgery at the School of Veterinary Medicine, University of Zurich, have developed TTA to allow neutralization of cranial tibial thrust without compromising joint congruency. This technique was a major departure from conventional practice. Since 2004, KYON’s TTA procedure has been used in over 50,000 cases by more than 700 surgeons and has become an important addition to the canine cranial cruciate repair armamentarium.
read publications on Tibial Tuberosity Advancement>>
The rapid acceptance of TTA has motivated several other companies to offer similar implants. KYON has neither collaborated with nor endorsed any of the competitors in the manufacture, promotion or sale of their TTA systems. KYON Pharma, Inc. is the only authorized distributor of KYON products in the United States.
- TTA neutralizes cranial tibial thrust in cranial cruciate deficient stifles.
- Stability is achieved without compromising joint congruency.
- TTA decreases internal joint reactions including retro-patellar pressure.
- TTA is less invasive than other geometry modifying techniques.
- TTA reduces morbidity and post-surgical complications while accelerating recovery.
- Sound biomechanical rationale
- Simplified surgical procedure
- Unique implants designed specifically for TTA
- Superb biocompatibility of titanium
- Broad range of sizes available
Cranial Cruciate Ligament (CCL) rupture is one of the most common causes of rear limb lameness in the dog. What causes CCL rupture? What are the consequences of CCL rupture and what is the treatment history? read more>>
TTA neutralizes cranial tibial thrust in cranial cruciate deficient stifles. What does this mean? What is the rationale behind TTA? What are the benefits? read more>>
KYON invented, developed, and introduced the TTA (Tibial Tuberosity Advancement) procedure for cranial cruciate deficiency in dogs. This technique was a major departure from conventional practice. What is the TTA innovation and how did KYON bring this innovation to the veterinary community? read more>>